A latest report has been added to the wide database of Antibacterial Drugs Market by Infinium Global Research. This report studies
the Antibacterial Drugs Market by drug class (quinolones, tetracycline, sulfonamide, b – lactams, macrolides, aminoglycoside,
phenicols), routes of administration (parenteral, enteral), distribution channel (drug stores and retail pharmacies, hospital pharmacies,
online sales) market status and outlook of global and major regions, from manufacturers, and end industries. The objective of the
study is to identify market sizes of different segments & countries in recent years and to forecast the values for the next six years.
Antibacterial Drugs Market provides opportunities in micro markets for stakeholders to invest along with the detailed analysis of
competitive landscape, latest trends, and product offerings of the major companies in the Antibacterial Drugs Market. According to
report the global antibacterial drugs market is expected to grow at a CAGR of 4.1% over the forecast period of 2017 - 2023.
Segments Covered
The report on global antibacterial drugs market covers segments such as drug class, routes of administration, and distribution channel.
The drug class segments include quinolones, tetracycline, sulfonamide, b – lactams, macrolides, aminoglycoside, phenicols and others.
On the basis of routes of administration the global antibacterial drugs market is categorized into parenteral, enteral and others.
Furthermore, on the basis of distribution channel the antibacterial drugs market is segmented as drug stores and retail pharmacies,
hospital pharmacies and online sales.
Geographic Coverage
The report provides regional analysis covering geographies such as North America, Europe, Asia-Pacific, and Rest of the World. In this
section the key trends and market size for each geography is provided over the period of 2015 – 2023. The countries covered in the
North America region include the U.S., Canada, and Mexico; while Asia-Pacific includes China, Japan, India, South Korea, Malaysia, and
among others. Moreover, Germany, U.K., France, Spain, and Rest of Europe are included in the European region. The U.S. drives the
growth in the North America region as it is the largest market in the region. The Asia-pacific region offers a substantial potential for the
market growth owing to rapid growth in markets such as India and China. The APAC region is projected to experience a growth at a
CAGR of x.x% over the period of 2017 - 2023.
Companies Profiled:
The report provides profiles of the companies in the global antibacterial drugs market such as, Pfizer Inc., GlaxoSmithKline Plc,